Odatron 4 mg/5 ml (Oral Solution)
50 ml bottle: ৳ 46.00
Medicine Details
Category | Details |
---|---|
Generic | Ondansetron |
Company | Pacific pharmaceuticals ltd |
Also available as |
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy
- Prevention and treatment of post-operative nausea and vomiting
- Prevention of radiotherapy-induced nausea and vomiting
Dosage
- 8 mg tablet/orodispersible tablet
- 4 mg orodispersible tablet
- Injection
- Oral Solution
- Highly emetogenic cancer chemotherapy
- Moderate emetogenic cancer chemotherapy
- Pediatric dose
- Total body irradiation
- Single high-dose fraction radiotherapy to the abdomen
- Daily fractionated radiotherapy to the abdomen
- Postoperative nausea and vomiting
- Dosage Adjustment for Patients With Impaired Renal Function
- Dosage Adjustment for Patients With Impaired Hepatic Function
- 4 years of age or younger
- Over the age of 65
Administration
- Orally dissolving film designed to be applied on top of the tongue
- Does not require water to aid dissolution or swallowing
- Swallowed with saliva
- Simple 5-step administration process
Interaction
Metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes, inducers or inhibitors may change the clearance and half-life of Odatron
Contraindications
Contraindicated in patients known to have hypersensitivity to the drug or any of its components, Concomitant use of apomorphine
Side Effects
- Headache
- Constipation
- Diarrhea
- Rash
- Sensation of flushing or warmth
- Hiccups
- Liver enzyme abnormalities
- Anaphylaxis
- Brochospasm
- Tachycardia
- Angina
- Hypokalemia
- Shortness of breath
- No evidence of extrapyramidal reactions
Pregnancy & Lactation
No evidence of impaired fertility or harm to the fetus due to Ondansetron, Caution advised when administered to nursing women
Precautions & Warnings
- Hypersensitivity reactions reported
- Not a drug that stimulates gastric or intestinal peristalsis
Use in Special Populations
- Dosage Adjustment for Patients With Impaired Renal Function
- Dosage Adjustment for Patients With Impaired Hepatic Function
- Little information for pediatric patients 4 years of age or younger
- No dosage adjustment needed in patients over the age of 65
Therapeutic Class
Anti-emetic drugs
Storage Conditions
Store at temperature not exceeding 30°C in a dry place, Protect from light and moisture